Stegent Equity Advisors, Inc. Abb Vie Inc. Transaction History

Stegent Equity Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $566,376 - $661,400	-3,659 Reduced 65.62%	1,917 $328,000
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $635,604 - $724,211	3,977 Added 248.72%	5,576 $1.02 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $220,022 - $247,797	1,599 New	1,599 $247,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Stegent Equity Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Stegent Equity Advisors, Inc. with notifications on news.